Medicine and Dentistry
Analysis
18%
Biological Marker
16%
Biopsy Technique
17%
Brain Metastasis
100%
Brainstem
21%
Brainstem Auditory Evoked Potential
15%
Breast Cancer
16%
Clear Cell Renal Cell Carcinoma
16%
Closed Head Injury
30%
Congenital Malformation
16%
Conservative Treatment
13%
COVID-19
13%
Epileptic Seizure
15%
Experience
20%
Follow up
16%
Glioblastoma
27%
Hearing Impairment
44%
Hemifacial Spasm
84%
Hepatocellular Carcinoma
16%
Hydrocephalus
14%
Immune Checkpoint Inhibitor
16%
Indocyanine Green
16%
Intracranial Tumor
45%
Lesion
27%
Magnetic Resonance Imaging
36%
Malignant Ascites
16%
Meta-Analysis
16%
Metastatic Carcinoma
27%
Microvascular Decompression
50%
Middle Cranial Fossa
16%
Neoplasm
82%
Nervous System Injury
16%
Non Small Cell Lung Cancer
74%
Overall Survival
47%
Patient
97%
Pediatric Brain Tumor
16%
Pituitary Adenoma
18%
Postoperative Complication
26%
Prognostic Factor
17%
Progression Free Survival
27%
Radiosurgery
25%
Recurrent Disease
44%
Stereotactic Radiosurgery
40%
Subdural Hematoma
44%
Surgery
38%
Survival
16%
Systemic Therapy
16%
Therapeutic Procedure
17%
Trigeminal Neuralgia
50%
Ventricle of Heart
25%
Neuroscience
Acoustic Neuroma
5%
Adrenocorticotropic Hormone
8%
Anticonvulsant
8%
Astrocytoma
5%
Behavior (Neuroscience)
8%
Brain
8%
Brain Lesion
19%
Brain Trauma
5%
Brainstem
11%
Closed Head Injury
17%
Computed Tomography
5%
Craniopharyngioma
16%
Cranioplasty
8%
Evoked Brain Stem Auditory Response
25%
Facial Nerve
8%
Germ Cell
5%
Hearing Loss
19%
Hematoma
5%
High Density Lipoprotein Cholesterol
8%
Histology
8%
Hydrocephalus
16%
Intracranial Tumor
50%
Isocitrate Dehydrogenase 1
8%
Isocitrate Dehydrogenase 1
8%
Magnetic Resonance Imaging
16%
Magnetic Resonance Imaging
12%
Mammillary Body
5%
Medial Longitudinal Fasciculus
10%
Meningioma
7%
Meningioma
5%
Meta-Analysis
8%
Metastasis
16%
Minoxidil
8%
Optic Nerve
5%
Pediatric Brain Tumor
16%
Pilocytic Astrocytoma
5%
Pituitary Adenoma
8%
Pituitary Adenoma
8%
Posterior Cranial Fossa
5%
Pupillary Reflex
8%
Schwannoma
12%
Skull
6%
Skull Base
8%
Subdural Hematoma
37%
Subdural Hematoma
8%
Suprasellar Area
5%
Third Ventricle
5%
Trigeminal Neuralgia
33%
Trigeminal Neuralgia
16%
Pharmacology, Toxicology and Pharmaceutical Science
Adenocarcinoma
5%
Anaplastic Lymphoma Kinase
5%
Barrow (Swine)
5%
Biological Marker
8%
Biological Marker
8%
Brain Metastasis
58%
Brain Metastasis
16%
Cerebrovascular Accident
8%
Congenital Malformation
8%
Emergency
8%
Enbucrilate
8%
Epidermal Growth Factor Receptor
5%
Epidermal Growth Factor Receptor
5%
Face Pain
8%
Hearing Impairment
11%
Hematoma
5%
Hemifacial Spasm
8%
High Density Lipoprotein Cholesterol
8%
Immune Checkpoint Inhibitor
8%
Injury
8%
Intracranial Tumor
22%
Lung Cancer
8%
Malignant Ascites
8%
Meningioma
5%
Minoxidil
5%
Neoplasm
23%
Neurilemoma
5%
Non Small Cell Lung Cancer
33%
Non Small Cell Lung Cancer
16%
Overall Survival
24%
Overall Survival
9%
Progression Free Survival
9%
Radiation Necrosis
12%
Recurrent Disease
26%
Subdural Hematoma
33%
Survival
8%
Survival Rate
8%
Survival Time
5%
Systemic Treatment
16%
Trigeminus Neuralgia
16%
